Volume : IX, Issue : III, March - 2020

NT–pro BNP Levels as a Biomarker for Cardioembolic Stroke

Dr Ananya Sengupta, Dr Neera Chaudhry

Abstract :

Stroke is a leading cause of mortality and morbidity. Stroke may be ischemic or hemorrhagic. Ischemic stroke may be due to cardioembolism, large vessel disease, small vessel disease or multiple pathologies. Of them, cardioembolism is the commonest etiology, accounting for up to 40% of all ischemic strokes, having higher recurrence rates as well as poorer outcomes. Atrial fiillation is the commonest cause of cardioembolism. The treatment also involves anticoagulants and not antiplatelets. Unfortunately detection of cardioembolism requires complicated long term monitoring through devices to detect paroxysmal atrial fiillation, which is as deadly as persistent atrial fiillation. The use of biomarkers would simplify the process of detecting cardioembolism, leading also to earlier detection. NT–pro BNP is one such biomarker, which has been shown to be useful in identifying cardioembolic stroke within 72 hrs of symptom onset. This review addresses the role of NT–pro BNP in the detection of cardioembolic stroke

Keywords :

Article: Download PDF    DOI : 10.36106/ijsr/3400580  

Cite This Article:

NT-PRO BNP LEVELS AS A BIOMARKER FOR CARDIOEMBOLIC STROKE, Dr Ananya Sengupta, Dr Neera Chaudhry INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-9 | Issue-3 | March-2020

Number of Downloads : 652

References :